Brokerages Set Simulations Plus, Inc. (NASDAQ:SLP) Price Target at $26.50

Key Points

• Simulations Plus, Inc. has received a consensus recommendation of "Moderate Buy" from analysts, with an average 12-month price target of $26.50 among the seven brokerages covering the company.
• The company's most recent earnings report showed $0.45 EPS, exceeding the consensus estimate of $0.26, despite a revenue of $20.36 million which fell short of the expected $22.83 million.
• Institutional investors hold 78.08% of Simulations Plus' stock, with notable increases in holdings by firms like Conestoga Capital Advisors and Ameriprise Financial in the past quarters.

Shares of Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven brokerages that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $26.50.

SLP has been the subject of several analyst reports. William Blair reissued an "outperform" rating on shares of Simulations Plus in a report on Tuesday, July 15th. BTIG Research reduced their price target on shares of Simulations Plus from $41.00 to $25.00 and set a "buy" rating for the company in a report on Monday, July 7th. Craig Hallum reduced their price target on shares of Simulations Plus from $45.00 to $36.00 and set a "buy" rating for the company in a report on Friday, June 13th. Wall Street Zen raised shares of Simulations Plus from a "sell" rating to a "hold" rating in a report on Monday, April 28th. Finally, Stephens cut their price objective on shares of Simulations Plus from $28.00 to $20.00 and set an "overweight" rating on the stock in a research note on Tuesday, July 15th.

Institutional Investors Weigh In On Simulations Plus

A number of hedge funds and other institutional investors have recently modified their holdings of SLP. LPL Financial LLC bought a new stake in shares of Simulations Plus during the fourth quarter valued at about $230,000. Wells Fargo & Company MN raised its position in Simulations Plus by 16.1% in the fourth quarter. Wells Fargo & Company MN now owns 41,161 shares of the technology company's stock worth $1,148,000 after acquiring an additional 5,704 shares in the last quarter. Renaissance Technologies LLC raised its position in Simulations Plus by 46.0% in the fourth quarter. Renaissance Technologies LLC now owns 45,100 shares of the technology company's stock worth $1,258,000 after acquiring an additional 14,200 shares in the last quarter. Barclays PLC raised its position in Simulations Plus by 2.7% in the fourth quarter. Barclays PLC now owns 29,229 shares of the technology company's stock worth $815,000 after acquiring an additional 756 shares in the last quarter. Finally, Marshall Wace LLP raised its position in Simulations Plus by 116.2% in the fourth quarter. Marshall Wace LLP now owns 102,077 shares of the technology company's stock worth $2,847,000 after acquiring an additional 54,858 shares in the last quarter. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Trading Up 5.8%

Simulations Plus stock traded up $0.80 during mid-day trading on Wednesday, reaching $14.57. The company's stock had a trading volume of 562,076 shares, compared to its average volume of 434,186. Simulations Plus has a twelve month low of $12.39 and a twelve month high of $37.67. The firm has a market cap of $293.29 million, a price-to-earnings ratio of -4.63 and a beta of 0.76. The business has a 50 day moving average price of $15.32 and a 200-day moving average price of $25.00.

Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings results on Monday, July 14th. The technology company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.19. Simulations Plus had a negative net margin of 78.63% and a positive return on equity of 11.62%. The company had revenue of $20.36 million during the quarter, compared to the consensus estimate of $22.83 million. During the same quarter in the previous year, the company posted $0.27 earnings per share. The company's revenue for the quarter was up 9.8% compared to the same quarter last year. On average, equities analysts expect that Simulations Plus will post 1.09 EPS for the current fiscal year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.